DNTH vs FOX · rev $6.2M vs P/E 13, rev $16.30B
Dianthus Therapeutics Inc. (DNTH) versus Fox Corp Class B (FOX) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported FOX revenue for 2025-06-30 was $16.30B. Net income was $2.29B. Revenue was up 16.6% from 2024-06-30 to 2025-06-30. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
DNTH currently screens at market cap $4.40B. FOX currently screens at market cap $24.49B and trailing P/E 13.0.
Not investment advice. Open the DNTH and FOX stock pages for the full models.
Not investment advice.